Inflammatory Bowel Diseases

Skip Navigation LinksHome > July 2013 - Volume 19 - Issue 8 > Multidimensional Prognostic Risk Assessment Identifies Assoc...
Inflammatory Bowel Diseases:
doi: 10.1097/MIB.0b013e318281f275
Original Clinical Articles

Multidimensional Prognostic Risk Assessment Identifies Association Between IL12B Variation and Surgery in Crohn’s Disease

Dubinsky, Marla C. MD*; Kugathasan, Subra MD; Kwon, Soonil PhD; Haritunians, Talin PhD; Wrobel, Iwona MD§; Wahbeh, Ghassan MD; Quiros, Antonio MD; Bahar, Ron MD*; Silber, Gary MD**; Farrior, Sharmayne RN*; Stephens, Michael MD††; Teleten, Nick‡‡; Panikkath, Deepa‡‡; Ippoliti, Andrew MD‡‡; Vasiliauskas, Eric MD‡‡; Fleshner, Phillip MD§§; Williams, Chadwick MD‡‡; Landers, Carol‡‡; Rotter, Jerome I. MD; Targan, Stephan R. MD‡‡; Taylor, Kent D. PhD; McGovern, Dermot P. B. MD, PhD‡,‡‡

Supplemental Author Material
Collapse Box


Background: The ability to identify patients with Crohn’s disease (CD) at highest risk of surgery would be invaluable in guiding therapy. Genome-wide association studies have identified multiple IBD loci with unknown phenotypic consequences. The aims of this study were to: (1) identify associations between known and novel CD loci with early resective CD surgery and (2) develop the best predictive model for time to surgery using a combination of phenotypic, serologic, and genetic variables.

Methods: Genotyping was performed on 1,115 subjects using Illumina-based genome-wide technology. Univariate and multivariate analyses tested genetic associations with need for surgery within 5 years. Analyses were performed by testing known CD loci (n = 71) and by performing a genome-wide association study. Time to surgery was analyzed using Cox regression modeling. Clinical and serologic variables were included along with genotype to build predictive models for time to surgery.

Results: Surgery occurred within 5 years in 239 subjects at a median time of 12 months. Three CD susceptibility loci were independently associated with surgery within 5 years (IL12B, IL23R, and C11orf30). Genome-wide association identified novel putative loci associated with early surgery: 7q21 (CACNA2D1) and 9q34 (RXRA, COL5A1). The most predictive models of time to surgery included genetic and clinical risk factors. More than a 20% difference in frequency of progression to surgery was seen between the lowest and highest risk groups.

Conclusions: Progression to surgery is faster in patients with CD with both genetic and clinical risk factors. IL12B is independently associated with need and time to early surgery in CD patients and justifies the investigation of novel and existing therapies that affect this pathway.

© Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.